• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实时逆转录聚合酶链反应快速预测药物敏感性的奥司他韦耐药变异体的人群分析。

Population analysis of oseltamivir-resistant variants for the rapid prediction of drug susceptibility by real-time reverse transcription polymerase chain reaction.

机构信息

Department of Pediatrics, Fukushima Medical University.

出版信息

Fukushima J Med Sci. 2022 Dec 21;68(3):153-159. doi: 10.5387/fms.2022-15. Epub 2022 Aug 31.

DOI:10.5387/fms.2022-15
PMID:36047170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9840889/
Abstract

This study investigated whether quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR), using specific probes composed of locked nucleic acids (LNA/qRT-PCR), designed to evaluate H1N1 pdm09 H275Y, H3N2 E119V and R292K variant populations, could replace a neuraminidase (NA) inhibition assay to determine the 50% inhibitory concentration (IC) of NA activity.For H1N1 pdm09, when the H275Y variant RNA load was 50% or 70% and the infective H275Y variant load was 40% or 70%, the IC were >10- and 100-fold higher, respectively, than that of the wild-type (WT) strain. For H3N2, when the E119V RNA load and infective E119V variant load were >90% and >60%, respectively, the IC of the mixed sample was >10-fold higher than that of the WT strain. The variant-mixed samples with a 70% or 80% R292K variant RNA load and a 60% or 70% infective R292K variant load exhibited >10- and 100-fold decreased susceptibility, respectively, compared with that of the WT. A positive correlation between the variant RNA load and infective variant load populations was observed.The LNA/qRT-PCR method can be used to improve the treatment and management of patients during antiviral therapy for influenza virus infection.

摘要

本研究旨在探讨使用针对 H1N1 pdm09 H275Y、H3N2 E119V 和 R292K 变异株设计的、包含锁核酸(LNA)的实时荧光定量逆转录聚合酶链反应(qRT-PCR)(LNA/qRT-PCR),是否可以替代神经氨酸酶(NA)抑制测定法来确定 NA 活性的 50%抑制浓度(IC)。对于 H1N1 pdm09,当 H275Y 变异 RNA 载量为 50%或 70%,感染性 H275Y 变异载量为 40%或 70%时,IC 值分别比野生型(WT)株高 10 倍和 100 倍。对于 H3N2,当 E119V RNA 载量和感染性 E119V 变异载量分别大于 90%和 60%时,混合样本的 IC 值比 WT 株高 10 倍以上。当 70%或 80%的 R292K 变异 RNA 载量和 60%或 70%的感染性 R292K 变异载量时,变异混合样本的敏感性分别比 WT 株降低 10 倍和 100 倍。观察到变异 RNA 载量与感染性变异株群体之间存在正相关。LNA/qRT-PCR 方法可用于改善流感病毒感染患者在抗病毒治疗期间的治疗和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5214/9840889/6ec8136e1e5f/2185-4610-68-153-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5214/9840889/e2b1d89cf043/2185-4610-68-153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5214/9840889/38df85f0da0d/2185-4610-68-153-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5214/9840889/7c28cc93ed49/2185-4610-68-153-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5214/9840889/6ec8136e1e5f/2185-4610-68-153-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5214/9840889/e2b1d89cf043/2185-4610-68-153-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5214/9840889/38df85f0da0d/2185-4610-68-153-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5214/9840889/7c28cc93ed49/2185-4610-68-153-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5214/9840889/6ec8136e1e5f/2185-4610-68-153-g004.jpg

相似文献

1
Population analysis of oseltamivir-resistant variants for the rapid prediction of drug susceptibility by real-time reverse transcription polymerase chain reaction.实时逆转录聚合酶链反应快速预测药物敏感性的奥司他韦耐药变异体的人群分析。
Fukushima J Med Sci. 2022 Dec 21;68(3):153-159. doi: 10.5387/fms.2022-15. Epub 2022 Aug 31.
2
Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction.通过实时逆转录聚合酶链反应对临床标本中甲型流感病毒(H3N2)E119V和R292K变体进行定量分析。
J Clin Virol. 2015 Jul;68:97-103. doi: 10.1016/j.jcv.2015.05.018. Epub 2015 May 23.
3
Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis.通过单核苷酸多态性分析对甲型流感病毒神经氨酸酶抑制剂耐药相关突变进行新型基因分型和定量分析。
Antimicrob Agents Chemother. 2011 Oct;55(10):4718-27. doi: 10.1128/AAC.00316-11. Epub 2011 Jul 5.
4
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.2013 - 2014年全球人类流感病毒对神经氨酸酶抑制剂敏感性的最新情况
Antiviral Res. 2015 May;117:27-38. doi: 10.1016/j.antiviral.2015.02.003. Epub 2015 Feb 23.
5
Impact on antiviral resistance of E119V, I222L and R292K substitutions in influenza A viruses bearing a group 2 neuraminidase (N2, N3, N6, N7 and N9).对携带2组神经氨酸酶(N2、N3、N6、N7和N9)的甲型流感病毒中E119V、I222L和R292K替代对抗病毒耐药性的影响。
J Antimicrob Chemother. 2016 Nov;71(11):3036-3045. doi: 10.1093/jac/dkw275. Epub 2016 Jul 17.
6
Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.在N1和N2基因背景下,神经氨酸酶突变赋予流感病毒对神经氨酸酶抑制剂耐药性的影响。
Antivir Ther. 2006;11(8):971-6.
7
Bioluminescence-based neuraminidase inhibition assay for monitoring influenza virus drug susceptibility in clinical specimens.基于生物发光的神经氨酸酶抑制assay 用于监测临床标本中的流感病毒药物敏感性。
Antimicrob Agents Chemother. 2013 Nov;57(11):5209-15. doi: 10.1128/AAC.01086-13. Epub 2013 Aug 5.
8
Characterization of oseltamivir-resistant influenza virus populations in immunosuppressed patients using digital-droplet PCR: Comparison with qPCR and next generation sequencing analysis.应用数字液滴 PCR 对免疫抑制患者中奥司他韦耐药流感病毒群体进行特征分析:与 qPCR 和下一代测序分析的比较。
Antiviral Res. 2017 Sep;145:160-167. doi: 10.1016/j.antiviral.2017.07.021. Epub 2017 Aug 3.
9
Rapid detection of the S247N neuraminidase mutation in influenza A(H1N1)pdm09 virus by one-step duplex RT-PCR assay.一步法双重 RT-PCR 检测流感 A(H1N1)pdm09 病毒 S247N 神经氨酸酶突变。
J Virol Methods. 2013 Mar;188(1-2):73-5. doi: 10.1016/j.jviromet.2012.12.005. Epub 2012 Dec 20.
10
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.2004年至2008年全球流行的甲型和乙型人流感病毒中神经氨酸酶抑制剂耐药性监测
Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.

本文引用的文献

1
Quantitative analysis of influenza A (H3N2) E119V and R292K variants in clinical specimens by real-time reverse transcription polymerase chain reaction.通过实时逆转录聚合酶链反应对临床标本中甲型流感病毒(H3N2)E119V和R292K变体进行定量分析。
J Clin Virol. 2015 Jul;68:97-103. doi: 10.1016/j.jcv.2015.05.018. Epub 2015 May 23.
2
Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan.2013 - 2014年日本流感季节期间对奥司他韦和帕拉米韦交叉耐药的一大群甲型H1N1pdm09流感病毒的特征分析
Antimicrob Agents Chemother. 2015 May;59(5):2607-17. doi: 10.1128/AAC.04836-14. Epub 2015 Feb 17.
3
Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants.
单次给药后流感病毒载量及帕拉米韦动力学,以及针对耐药变异株的帕拉米韦给药方案建议
Antimicrob Agents Chemother. 2015 Mar;59(3):1643-9. doi: 10.1128/AAC.04263-14. Epub 2014 Dec 29.
4
Sequential influenza B viral load and susceptibility in children treated with oseltamivir and zanamivir.奥司他韦和扎那米韦治疗儿童的流感 B 病毒载量和敏感性的顺序变化。
Pediatr Infect Dis J. 2014 Jul;33(7):e168-72. doi: 10.1097/INF.0000000000000266.
5
A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013.日本 2013 年 11 月至 12 月出现的具有交叉耐药性的甲型 H1N1pdm09 流感病毒社区集群
Euro Surveill. 2014 Jan 9;19(1):20666. doi: 10.2807/1560-7917.es2014.19.1.20666.
6
Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria.2011-2012 年美国流行的流感病毒的药物敏感性监测:世卫组织抗病毒工作组标准的应用。
Influenza Other Respir Viruses. 2014 Mar;8(2):258-65. doi: 10.1111/irv.12215. Epub 2013 Dec 2.
7
Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations.用于流感病毒定量和定性检测及奥司他韦耐药突变的分子检测方法。
J Mol Diagn. 2013 May;15(3):347-54. doi: 10.1016/j.jmoldx.2012.11.007. Epub 2013 Apr 16.
8
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS).2008-2011 年神经氨酸酶抑制剂耐药性的全球评估:流感耐药信息研究(IRIS)。
Clin Infect Dis. 2013 May;56(9):1197-205. doi: 10.1093/cid/cis1220. Epub 2013 Jan 10.
9
Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.2010-2011 年美国耐奥司他韦的大流行性(H1N1)2009 病毒感染。
Emerg Infect Dis. 2012 Feb;18(2):308-11. doi: 10.3201/eid1802.111466.
10
Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis.通过单核苷酸多态性分析对甲型流感病毒神经氨酸酶抑制剂耐药相关突变进行新型基因分型和定量分析。
Antimicrob Agents Chemother. 2011 Oct;55(10):4718-27. doi: 10.1128/AAC.00316-11. Epub 2011 Jul 5.